Metabolic syndrome treatment strategiesFUJIOKA, Ken.Pharmacotherapy. 2006, Vol 26, Num 12, issn 0277-0008, 222S-226S, 2Conference Paper

Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulationFUJIOKA, Ken; PANS, Miranda; JOYAL, Steven et al.Clinical therapeutics. 2003, Vol 25, Num 2, pp 515-529, issn 0149-2918, 15 p.Article

Nutrition Therapy of the Severely Obese, Critically Ill Patient: Summation of Conclusions and RecommendationsMCCLAVE, Stephen A; KUSHNER, Robert; GALLAGHER, Dympna et al.JPEN. Journal of parenteral and enteral nutrition. 2011, Vol 35, issn 0148-6071, 88S-96S, SUP1Article

Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical TrialIKRAMUDDIN, Sayeed; BLACKSTONE, Robin P; MORTON, John M et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 9, pp 915-922, issn 0098-7484, 8 p.Article

Nutrition and Metabolic Complications After Bariatric Surgery and Their TreatmentFUJIOKA, Ken; DIBAISE, John K; MARTINDALE, Robert G et al.JPEN. Journal of parenteral and enteral nutrition. 2011, Vol 35, issn 0148-6071, 52S-56S, SUP1Article

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and PlaceboGREENWAY, Frank L; DUNAYEVICH, Eduardo; TOLLEFSON, Gary et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 12, pp 4898-4906, issn 0021-972X, 9 p.Article

Effects of sibutramine treatment in obese adolescents : A randomized trial. CommentaryDIETZ, William H; BERKOWITZ, Robert I; WALCH, Julia K et al.Annals of internal medicine. 2006, Vol 145, Num 2, issn 0003-4819, 145-146,81-90 [12 p.]Article

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 DiabetesHOLLANDER, Priscilla; GUPTA, Alok K; PLODKOWSKI, Raymond et al.Diabetes care. 2013, Vol 36, Num 12, pp 4022-4029, issn 0149-5992, 8 p.Article

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialGREENWAY, Frank L; FUJIOKA, Ken; PLODKOWSKI, Raymond A et al.Lancet (British edition). 2010, Vol 376, Num 9741, pp 595-605, issn 0140-6736, 11 p.Article

Obesity : Why Be Concerned?VIRGIL BROWN, W; FUJIOKA, Ken; WILSON, Peter W. F et al.The American journal of medicine. 2009, Vol 122, Num 4A, issn 0002-9343, S4-S11, SUPArticle

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects : A phase 2, randomized, placebo-controlled, dose-escalation studyARONNE, Louis; FUJIOKA, Ken; ARODA, Vanita et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 8, pp 2977-2983, issn 0021-972X, 7 p.Article